James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 50,000 shares at $20.12 ($1.0M) on 2022-11-15, disclosed to the SEC on 2024-03-29.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.12 | 46,500 | $936K | 92.2% |
| 2 | $21.18 | 1,600 | $34K | 3.3% |
| 3 | $21.97 | 200 | $4K | 0.4% |
| 4 | $24.02 | 1,700 | $41K | 4.0% |
| Total | $20.29 avg | 50,000 | $1.0M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |